Anthony Sung

Associate Professor of Medicine
Anthony Sung


I am dedicated to the treatment of hematologic malignancies through cellular therapies such as hematopoietic stem cell transplantation (HCT). My research focuses on strategies to reduce complications of HCT and ranges from preclinical studies using murine models of HCT to Phase 1 and Phase 2 clinical trials. Areas of interest include the role of the microbiota (the trillions of bacteria living in and on our bodies), nutrition, and exercise in modulating HCT outcomes such as graft-versus-host disease (GVHD) and infections. In addition to advancing new pharmacological and cellular immunotherapies in support of these goals, we also are developing mobile health technologies (mHealth) to monitor patients at home, both as part of our innovative home transplant program as well as to improve follow up care of all our patients when they return home after transplant.


Associate Professor of Medicine in the School of Medicine

2021 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2016 School of Medicine

Senior Fellow in the Center for the Study of Aging and Human Development in the School of Medicine

2020 School of Medicine


M.D. 2008

2008 Harvard University

Residency, Osler Medical Housestaff Training Program

2011 Johns Hopkins University School of Medicine

Fellowship, Hematology Oncology

2014 Duke University School of Medicine

Clinical Trials

Publications, Grants & Awards

DCI Centers, Cancer Types & Labs

Offices & Contact

Box 3961 Med Ctr
Durham, NC
Cellular Therapy Abmt, Box 3961 DUMC
Durham, NC